Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis

NCT00812045 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: AZD1236
DRUG: Placebo

Sponsor

AstraZeneca